Distinctive Brain Malformations in Zhu-Tokita-Takenouchi-Kim Syndrome

References

1. 1.↵
   1. Richards S,
   2. Aziz N,
   3. Bale S, et al

   ; ACMG Laboratory Quality Assurance Committee. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405–24 doi:10.1038/gim.2015.30 pmid:25741868

   CrossRefPubMed
2. 2.↵
   1. Zhu X,
   2. Petrovski S,
   3. Xie P, et al

   . Whole-exome sequencing in undiagnosed genetic diseases: Interpreting 119 trios. Genet Med 2015;17:774–81 doi:10.1038/gim.2014.191 pmid:25590979

   CrossRefPubMed
3. 3.↵
   1. Kim JH,
   2. Shinde DN,
   3. Reijnders MR, et al

   ; Deciphering Developmental Disorders Study. De novo mutations in SON disrupt RNA splicing of genes essential for brain development and metabolism, causing an intellectual-disability syndrome. Am J Hum Genet 2016;99:711–19 doi:10.1016/j.ajhg.2016.06.029 pmid:27545680

   CrossRefPubMed
4. 4.↵
   1. Tokita MJ,
   2. Braxton AA,
   3. Shao Y, et al

   . De novo truncating variants in SON cause intellectual disability, congenital malformations, and failure to thrive. Am J Hum Genet 2016;99:720–27 doi:10.1016/j.ajhg.2016.06.035 pmid:27545676

   CrossRefPubMed
5. 5.↵
   1. Takenouchi T,
   2. Miura K,
   3. Uehara T, et al

   . Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: possible contribution to Braddock-Carey syndrome phenotype. Am J Med Genet A 2016;170:2587–90 doi:10.1002/ajmg.a.37761 pmid:27256762

   CrossRefPubMed
6. 6.↵
   1. Sharma A,
   2. Markey M,
   3. Torres-Muñoz K, et al

   . SON maintains accurate splicing for a subset of human pre-mRNAs. J Cell Sci 2011;124:4286–98 doi:10.1242/jcs.092239 pmid:22193954

   Abstract/FREE Full Text
7. 7.
   1. Ahn EE,
   2. DeKelver RC,
   3. Lo MC, et al

   . SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell 2011;42:185–98 doi:10.1016/j.molcel.2011.03.014 pmid:21504830

   CrossRefPubMedWeb of Science
8. 8.
   1. Livyatan I,
   2. Meshorer E

   . SON sheds light on RNA splicing and pluripotency. Nat Cell Biol 2013;15:1139–40 doi:10.1038/ncb2851 pmid:24084863

   CrossRefPubMed
9. 9.
   1. Ueda M,
   2. Matsuki T,
   3. Fukada M, et al

   . Knockdown of SON, a mouse homologue of the ZTTK syndrome gene, causes neuronal migration defects and dendritic spine abnormalities. Mol Brain 2020;13:1–9 doi:10.1186/s13041-020-00622-4 pmid:32448361

   CrossRefPubMed
10. 10.↵
    1. Kim JH,
    2. Baddoo MC,
    3. Park EY, et al

    . SON and its alternatively spliced isoforms control MLL complex-mediated H3K4me3 and transcription of leukemia-associated genes. Mol Cell 2016;61:859–73 doi:10.1016/j.molcel.2016.02.024 pmid:26990989

    CrossRefPubMed
11. 11.↵
    1. Kushary ST,
    2. Revah-Politi A,
    3. Barua S, et al

    . ZTTK syndrome: clinical and molecular findings of 15 cases and a review of the literature. Am J Med Genet A 2021;185:3740–53 doi:10.1002/ajmg.a.62445] pmid:34331327

    CrossRefPubMed
12. 12.↵
    1. Dingemans AJ,
    2. Truijen KM,
    3. Kim JH, et al

    . Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON. Eur J Hum Genet 2022;30:271–81 doi:10.1038/s41431-021-00960-4 pmid:34521999

    CrossRefPubMed
13. 13.
    1. Kim JH,
    2. Park EY,
    3. Chitayat D, et al

    . SON haploinsufficiency causes impaired pre-mRNA splicing of CAKUT genes and heterogeneous renal phenotypes. Kidney Int 2019;95:1494–1504 doi:10.1016/j.kint.2019.01.025 pmid:31005274

    CrossRefPubMed
14. 14.↵
    1. Slezak R,
    2. Smigiel R,
    3. Rydzanicz M, et al

    . Phenotypic expansion in Zhu-Tokita-Takenouchi-Kim syndrome caused by de novo variants in the SON gene. Mol Genet Genomic Med 2020;8:1–7 doi:10.1002/mgg3.1432 pmid:32705777

    CrossRefPubMed
15. 15.↵
    1. Vriend I,
    2. Oegema R

    . Genetic causes underlying grey matter heterotopia. Eur J Paediatr Neurol 2021;35:82–92 doi:10.1016/j.ejpn.2021.09.015 pmid:34666232

    CrossRefPubMed
16. 16.↵
    1. Parrini E,
    2. Ramazzotti A,
    3. Dobyns WB, et al

    . Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin a mutations. Brain 2006;129:1892–1906 doi:10.1093/brain/awl125 pmid:16684786

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Heinzen EL,
    2. O’Neill AC,
    3. Zhu X, et al

    ; for the Epi4K Consortium. De novo and inherited private variants in MAP1B in periventricular nodular heterotopia. PLoS Genet 2018;14:e1007281–23 doi:10.1371/journal.pgen.1007281 pmid:29738522

    CrossRefPubMed
18. 18.↵
    1. Karczewski KJ,
    2. Francioli LC,
    3. MacArthur DG

    . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020;581:434–43 doi:10.1530/ey.17.14.3

    CrossRef
19. 19.↵
    1. Thormann A,
    2. Halachev M,
    3. McLaren W, et al

    . Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP. Nat Commun 2019;10:2373 doi:10.1038/s41467-019-10016-3 pmid:31147538

    CrossRefPubMed
20. 20.↵
    1. Garel C,
    2. Cont I,
    3. Alberti C, et al

    . Biometry of the corpus callosum in children: MR imaging reference data. AJNR Am J Neuroradiol 2011;32:1436–43 doi:10.3174/ajnr.A2542 pmid:21799035

    Abstract/FREE Full Text
21. 21.↵
    1. Jandeaux C,
    2. Kuchcinski G,
    3. Ternynck C, et al

    . Biometry of the cerebellar vermis and brain stem in children: MR imaging reference data from measurements in 718 children. AJNR Am J Neuroradiol 2019;40:1835–41 doi:10.3174/ajnr.A6257 pmid:31624120

    Abstract/FREE Full Text
22. 22.↵
    1. Broix L,
    2. Jagline H,
    3. Ivanova E, et al

    ; Deciphering Developmental Disorders Study. Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia. Nat Genet 2016;48:1349–58 doi:10.1038/ng.3676 pmid:27694961

    CrossRefPubMed
23. 23.↵
    1. Wieck G,
    2. Leventer RJ,
    3. Squier WM, et al

    . Periventricular nodular heterotopia with overlying polymicrogyria. Brain 2005;128:2811–21 doi:10.1093/brain/awh658 pmid:16311271

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Quintana Castanedo L,
    2. Sánchez Orta A,
    3. Maseda Pedrero R, et al

    . Skin and nails abnormalities in a patient with ZTTK syndrome and a de novo mutation in SON. Pediatr Dermatol 2020;37:517–19 doi:10.1111/pde.14113 pmid:32045494

    CrossRefPubMed
25. 25.↵
    1. Conti V,
    2. Carabalona A,
    3. Pallesi-Pocachard E, et al

    . Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene. Brain 2013;136:3378–94 doi:10.1093/brain/awt249 pmid:24056535

    CrossRefPubMed
26. 26.↵
    1. Myers KA,
    2. Mandelstam SA,
    3. Ramantani G, et al

    . The epileptology of Koolen-de Vries syndrome: electro-clinico-radiologic findings in 31 patients. Epilepsia 2017;58:1085–94 doi:10.1111/epi.13746 pmid:28440867

    CrossRefPubMed